Rare disease clinical trials present a distinct set of challenges that make sourcing strategies critical to study success. With fewer patients, limited historical data and small global treatment populations, every component of the trial must be executed with precision, especially the sourcing of comparator drugs and ancillary supplies. In rare disease studies patient recruitment is already difficult. Delays due to drug unavailability or supply chain inefficiencies can have a

Earlier this month, the US President signed a landmark executive order aimed at delivering “most favored nation” (MFN) pricing for...

Request A global listed Biotech company required large quantities of Eylea Pre-Filled Syringes (PFS) sourced across both the EU and USA. Their priorities included: Relatively Stable pricing over a 2-3 year period Best possible expiry dates to accommodate packaging timelines (losing 6-8 weeks in the process) Ensuring continuous supply by replenishing stock before expiry (~14-16 months) Bulk procurement in single large batches for efficiency in regular intervals Challenges Ma

Client Request A leading global biopharmaceutical company approached CSI with an urgent need for the Fluarix QIV Southern Hemisphere Vaccine 2025. The requirements included: Quantity: 10,000 doses Delivery Date: As soon as possible (urgent) Delivery Location: Singapore Batch Preference: Multiple lots acceptable if necessary The Challenge The client was let down by a supplier in Brazil and needed to secure alternative stock at the last minute. Complicating matters, the Fluarix

A Global Pharmaceutical Sponsor’s Challenge A global pharmaceutical sponsor conducting a Phase III clinical trial needed Semaglutide, a GLP-1 receptor agonist, as a comparator drug. The study spanned multiple regions, including North America, Europe, and Asia-Pacific. This required a consistent and compliant supply of the drug across various regulatory landscapes. The sponsor needed a reliable partner to source Semaglutide efficiently while ensuring batch consistency, Certifi

CSI attended the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas, April 27th-30th. The event brought together clinical supply professionals from around the world to discuss industry trends, challenges and strategies for your clinical trial pipeline. CSI’s Managing Director, Vanessa Dekou, hosted a successful and sell-out workshop at GCSG US, to share over 25 years’ worth of expert insights on the complexities of comparator sourcing strategies. If yo

Exciting news! CSI will be exhibiting at GCSG Asia Pacific 2024 this week, on March 12-13 in Seoul! Visit us at Table 7 to learn how our expert clinical supply solutions can streamline your global trial supplies. Let’s connect and explore how CSI’s direct manufacturer relationships, scientific expertise and sustainable sourcing can support your study needs. See you there! 👋

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...

At Clinical Services International (CSI), we continually strive to exceed the expectations of our pharmaceutical and biotech partners by...

Request: CSI was tasked with sourcing a vast quantity of Venetoclax and Azacitidine for a large pharmaceutical company's global study on...

CSI is excited to have our Managing Director Vanessa Dekou featured on the front cover of Life Sciences Magazine! This recognition is not only a personal achievement but a testament to the incredible work of the Clinical Services International team. We have been driving excellence in clinical trial services, making a real impact to clinical research and patients lives. Read the Life Sciences Review article here.

The CSI Team will be in Barcelona next month for Clinical Trial Supply Europe on 6th-7th March 2024. Visit Booth 42 to explore all of...

This month, we are focusing on Oncology and have reflected on the notable advancements to oncology medications in recent years....

Clinical trials are the backbone of medical research, serving as a critical step in evaluating the safety and efficacy of new drugs and treatments. A key element of conducting successful clinical trials is the careful selection and sourcing of comparator drugs. Comparators, also known as reference drugs, play a vital role in comparing the effects of the investigational drug to an established standard of care. We explore the significance of clinical trial comparator sourcing,

Ryvu Therapeutics Announces Entering into Agreement with Clinical Services International (CSI) in the Area of Securing Venetoclax Supply...

Direct to patient trials have surged in popularity in the wake of the coronavirus pandemic, offering several benefits to patients and...

Successful clinical trials need effective supply chain management procedures to make sure risks are identified and managed in a timely...

How can you be sure that your comparator sourcing partner will provide you with the best available solution? How do you know that the...